- Born:
- 1952, Berkeley, California, U.S. (age 74)
- Awards And Honors:
- Nobel Prize (2024)
- Subjects Of Study:
- RNA interference
- gene regulation
- microRNA
Gary Ruvkun
-
Who is Gary Ruvkun?
Gary Ruvkun (born in 1952) is an American molecular biologist and geneticist. He is known for his research on microRNA (miRNA) and RNA interference (RNAi), as well as his work on aging and longevity.
Ruvkun initially studied biophysics at the University of California, Berkeley, and later earned a Ph.D. in microbial genetics from Harvard University in 1982. He then became a postdoctoral researcher at the Massachusetts Institute of Technology, where he began his research on the genetics of temporal regulation of developmental events in the nematode Caenorhabditis elegans.
In 1985, Ruvkun joined the faculty at Massachusetts General Hospital and Harvard Medical School, where he continued his research on developmental genetics in C. elegans. In 2000, Ruvkun and his team described a novel miRNA encoded by let-7, a gene in C. elegans that is highly conserved and occurs across species. He was awarded the 2024 Nobel Prize for Physiology or Medicine with Victor Ambros for his contributions to the discovery of miRNA and its role in regulating gene activity.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What field of science does Gary Ruvkun work in?
Gary Ruvkun is an American molecular biologist and geneticist known for his work on aging and longevity, as well as his research on microRNA (miRNA) and RNA interference (RNAi). Molecular biology is a field of science that studies the chemical structures and processes of biological phenomena involving molecules, especially nucleic acids (DNA and RNA) and proteins, and how these molecules interact within cells. Genetics is the study of heredity and genes, exploring how genes act in cells and are transmitted from parents to offspring.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How did Gary Ruvkun's discovery of microRNAs change genetics research?
Gary Ruvkun's work, particularly his co-discovery of microRNA (miRNA) with Victor Ambros, has significantly impacted genetics research. Their research revealed that miRNAs regulate gene expression by silencing protein synthesis, a departure from the understood roles of other forms of RNA.
Ruvkun's work describing the let-7 gene showed that miRNAs are highly conserved across species. This discovery, along with the understanding that miRNA helps cells respond to environmental signals and control the timing and level of gene expression, has opened new avenues for understanding gene regulation and its connection to diseases. Aberrant miRNA expression is associated with diseases such as cancer, autoimmune disorders, cardiovascular disease, and neurodegenerative disorders.
4 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What organisms did Gary Ruvkun use for his genetic studies?
Gary Ruvkun primarily used Caenorhabditis elegans, a nematode, for his genetic studies of temporal regulation and developmental events. Ruvkun cloned the lin-14 gene in C. elegans and, with Victor Ambros, compared short lin-4 RNA sequences with lin-14 messenger RNA (mRNA). They discovered that lin-4 miRNA binding to lin-14 mRNA shuts down lin-14 activity. Later, Ruvkun and his team described a novel miRNA encoded by let-7, a gene in C. elegans that is highly conserved across species. Ruvkun also investigated genetic pathways involved in metabolism and longevity in C. elegans, compiling a catalog of genes involved in the regulation of metabolism and aging. Earlier in his career, Ruvkun investigated mechanisms of genetic control in bacterial cells.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How have Gary Ruvkun’s findings helped scientists understand diseases in humans?
Gary Ruvkun's research on microRNA (miRNA) has significantly advanced the understanding of gene regulation and its link to human diseases. Ruvkun's work, for which he shared the 2024 Nobel Prize, has revealed that miRNAs regulate gene expression by silencing protein synthesis.
His findings have shown that aberrant miRNA expression is associated with autoimmune diseases, cancer, cardiovascular disease, and neurodegenerative disorders. Certain miRNAs can act as oncogenes or tumor suppressors, influencing cell proliferation. This insight into how miRNAs control the timing and level of gene expression is crucial for understanding embryonic development and how cells respond to environmental signals.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
Gary Ruvkun (born 1952, Berkeley, California, U.S.) is an American molecular biologist and geneticist renowned for his groundbreaking research on microRNA (miRNA) and RNA interference (RNAi) as well as for his work on aging and longevity. In particular, his studies provided critical insight into the fundamental process of gene regulation and into cellular mechanisms involved in development. He was awarded the 2024 Nobel Prize for Physiology or Medicine (shared with American developmental biologist and molecular geneticist Victor Ambros) for his contributions to the discovery of miRNA and its role in regulating gene activity.
Education and early research
While growing up in California, Ruvkun expressed an interest in astronomy and radio communication. At the University of California, Berkeley, he initially planned to study electrical engineering, but he changed his mind and instead pursued a degree in biophysics. In 1973, after receiving a bachelor’s degree, he traveled north along the West Coast, through California and into Oregon, where for a brief time he helped plant trees for a cooperative near Eugene. He then spent a year traveling through South America before returning to the United States and a career in science.
After working as a technician in nuclear medicine at the University of California, San Francisco, for a year, Ruvkun applied and was accepted for graduate studies at Harvard University. He started there in 1976, investigating mechanisms of genetic control in bacterial cells. He earned a Ph.D. in microbial genetics in 1982 and subsequently became a postdoctoral researcher in the laboratory of biologist H. Robert Horvitz at the Massachusetts Institute of Technology. There he met Ambros and began his research on the genetics of temporal regulation of developmental events in the nematode Caenorhabditis elegans. In particular, the two scientists carried out studies on strains of C. elegans with mutations in the genes lin-4 and lin-14.
Lin-14 and let-7
In 1985 Ruvkun joined the faculty at Massachusetts General Hospital and Harvard Medical School and continued to research developmental genetics in C. elegans. He successfully cloned the lin-14 gene, and in the early 1990s, following Ambros’s observation that lin-4 produces a very short RNA molecule, they decided to compare the short lin-4 RNA sequence with a lin-14 messenger RNA (mRNA) sequence that Ruvkun had discovered. They found that the two sequences are complementary. In follow-up experiments, they also discovered that lin-4 miRNA binding to lin-14 mRNA shuts down lin-14 activity, preventing it from producing its corresponding protein.
These groundbreaking findings were initially greeted with skepticism, especially because they were thought to be irrelevant to other species. In 2000, however, Ruvkun and his team described a novel miRNA encoded by let-7, a gene in C. elegans that is highly conserved and that occurs across species. Since then numerous miRNAs have been discovered in many different organisms.
Later career
Ruvkun later investigated genetic pathways involved in metabolism and longevity in C. elegans. His laboratory ultimately compiled a catalog of genes that are involved in the regulation of metabolism and aging. He was also intrigued by the search for life on Mars and aimed to develop methods whereby soil from Mars could be probed for traces of ancient ribosomal RNA gene sequences.
Awards and honors
In addition to being honored with the Nobel Prize, Ruvkun has been recognized with many other awards during his career. Among them are the 2004 Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research (shared with Ambros, Craig C. Mello, and Andrew Z. Fire), the 2008 Canada Gairdner International Award (shared with Ambros and others), the 2008 Lasker Award for Basic Medical Research (shared with Ambros and David C. Baulcombe), and the 2014 Wolf Prize in Medicine (shared with Ambros and Nahum Sonenberg). Ruvkun is a fellow of the National Academy of Sciences (2008) and the American Academy of Arts and Sciences (2009).
The trusted destination for professionals, college students, and lifelong learners.
SUBSCRIBE
